NCT07663578

Brief Summary

The goal of this clinical trial is to learn how a non-invasive brain stimulation method called Temporally Interfering Electric Fields Stimulation (TIEFS) affects brain activity and thinking in adults. TIEFS uses electrical currents applied to the scalp to influence brain activity without surgery. The main questions this study aims to answer are:

  • How does TIEFS change brain signals measured with brain recordings?
  • Does TIEFS affect thinking abilities such as memory, language, movement, or perception?
  • Is TIEFS safe and well tolerated when used in people? This study includes two groups of participants. One group includes adults with epilepsy who are already undergoing specialized brain monitoring as part of their medical care. The other group includes healthy adults with no history of seizures. Participants will:
  • Receive brief sessions of TIEFS using electrodes placed on the scalp
  • Complete computer-based tasks that test memory, attention, language, or movement. Answer questions about how the stimulation feels
  • Have brain activity recorded during the study Each study visit lasts up to three hours and may occur in one or two sessions. Information from this study may help researchers better understand the human brain and support the development of future non-invasive brain stimulation treatments.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
8mo left

Started Apr 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress65%
Apr 2025Apr 2027

Study Start

First participant enrolled

April 16, 2025

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

June 16, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 23, 2026

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2027

Last Updated

June 23, 2026

Status Verified

June 1, 2026

Enrollment Period

2 years

First QC Date

June 16, 2026

Last Update Submit

June 16, 2026

Conditions

Keywords

Brain Stimulation

Outcome Measures

Primary Outcomes (1)

  • Brain activity changes during Stimulation

    This outcome measures the changes in brain activity, either measured through scalp EEG electrodes (in Healthy Participant controls), or intracranial stereotaxic EEG electrodes (for SEEG pre-surgical evaluation epilepsy patients). Local field potential (LFP) power and EEG power in response to active TIEFS stimulation will be compared to sham stimulation. Electrical signals recorded from the brain reflect neural activity. Intracranial signals will be measured across different locations in the brain using implanted SEEG electrodes. Additionally, SEEG electrodes may have tetrodes tips to capture single neuron activity. We will compare how the brain's electrical activity changes during active TIEFS at various frequencies and during the sham stimulation to assess the impact on brain and neural function.

    Measurements will be recorded throughout the stimulation session (lasting up to 90 minutes), with data collected before, during, and immediately after each stimulation.

Study Arms (2)

Comparison of Active vs Sham TIEFS Stimulation in SEEG patients

EXPERIMENTAL

This arm involves a within-subject comparison of different frequencies of active TIEFS stimulation and sham stimulation, all within the same session. Patients will already have been admitted to SEEG surgery, and will be approached while still having the electrodes implanted. Each participant will receive multiple types of stimulation at different envelope frequencies (ranging from 1-130 Hz). During the session, electrodes will be placed on the scalp to administer TIEFS at varying frequencies. Each frequency will be tested in separate trials within the session, with multiple trials per frequency. The results from these trials will be averaged to determine the overall impact of each frequency on brain activity (measured through SEEG) and/or cognitive functions (evaluated using tasks related to memory, language, motor function, and perception). Sham stimulation will also be delivered within the same session, and participants will be blinded to the type of stimulation (active vs sham).

Device: Temporal Interference Electrical Stimulation

Comparison of Active vs Sham TIEFS Stimulation in Healthy Subjects

EXPERIMENTAL

This arm involves a within-subject comparison of active and sham TIEFS stimulation in healthy control subjects. Participants will receive both active and sham stimulation in a single session, with different frequencies of TIEFS applied during active stimulation. The goal is to measure the changes in brain activity using EEG and assess the impact of TIEFS on cognitive functions such as memory, motor function, language, and perception. Participants will be blinded to the type of stimulation they are receiving during the session.

Device: Temporal Interference Electrical Stimulation

Interventions

Temporal Interference Electrical Stimulation (TIEFS) is a non-invasive brain stimulation technique that uses two high-frequency electrical fields (\>1 kHz) to generate an interference pattern at a specific brain region, creating a low-frequency envelope (Δf = f2 - f1) at the target depth. Unlike traditional stimulation methods, which affect only superficial brain regions, TIEFS can reach deeper structures without the need for implanted electrodes. The stimulation is applied through scalp electrodes. It has the potential for targeted brain interventions in both functional studies and clinical applications for neurological conditions.

Comparison of Active vs Sham TIEFS Stimulation in Healthy SubjectsComparison of Active vs Sham TIEFS Stimulation in SEEG patients

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants must be able to sufficiently speak and understand English or Spanish for consent and be able to understand and complete cognitive tasks.
  • All subjects must have the ability to give valid informed consent.

You may not qualify if:

  • No pregnant women will be recruited.
  • People with implanted electrical devices such as Deep Brain Stimulation devices or Pacemakers.
  • No prisoners will be recruited.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California Davis Medical Center

Sacramento, California, 95817, United States

RECRUITING

MeSH Terms

Conditions

Epilepsy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Nigel P Pedersen, MBBS

    University of California Davis, School of Medicine, Neurology Department

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nigel P Pedersen, MBBS

CONTACT

Raul S Castillo-Astorga, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants are masked to the type of stimulation they receive. They are not told whether the stimulation delivered during a session is active or sham. Researchers and study staff are aware of the stimulation type, and no other parties are masked in this clinical trial.
Purpose
BASIC SCIENCE
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 16, 2026

First Posted

June 23, 2026

Study Start

April 16, 2025

Primary Completion (Estimated)

April 15, 2027

Study Completion (Estimated)

April 15, 2027

Last Updated

June 23, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will share

Upon publication, anonymized individual participant data (IPD) will be shared as part of the supplementary materials. The shared data will include EEG recordings, cognitive task results (memory, language, motor, perception), and stimulation parameters (active vs sham, frequencies). All IPD will be de-identified, with personal identifiers removed to ensure confidentiality and compliance with HIPAA. The de-identified data will be made available through a repository or data-sharing platform, accessible to qualified researchers for scientific and educational use only.

Locations